CT UK Fund Institutional Gross Acc GBPRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | - | -5.6 | 12.1 | 4.8 | |
+/-Cat | - | - | -3.6 | 3.9 | -2.5 | |
+/-B’mrk | - | - | - | 4.5 | -3.4 | |
Category: UK Large-Cap Equity | ||||||
Category Benchmark: Morningstar UK All Cap TME ... |
Key Stats | ||
NAV 21/11/2024 | GBP 1.13 | |
Day Change | 0.22% | |
Morningstar Category™ | UK Large-Cap Equity | |
IA (formerly IMA) Sector | UK All Companies | |
ISIN | GB00BMW6N449 | |
Fund Size (Mil) 31/10/2024 | GBP 683.43 | |
Share Class Size (Mil) 21/11/2024 | GBP 1.09 | |
Max Initial Charge | - | |
Ongoing Charge 31/03/2024 | 1.62% |
Investment Objective: CT UK Fund Institutional Gross Acc GBP |
The Fund aims to achieve capital growth over the long term. It also looks to outperform the FTSE All-Share Index over rolling 3-year periods, after the deduction of charges. The Fund is actively managed, and invests at least 90% of its assets in shares of companies listed on the London Stock Exchange; predominantly companies domiciled in the UK, or which have significant UK business operations. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Gordon Happell 31/08/2023 | ||
Inception Date 01/11/2021 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE AllSh TR GBP | Morningstar UK All Cap TME NR GBP |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for CT UK Fund Institutional Gross Acc GBP | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
AstraZeneca PLC | Healthcare | 7.07 |
Shell PLC | Energy | 6.94 |
Unilever PLC | Consumer Defensive | 5.49 |
London Stock Exchange Group PLC | Financial Services | 3.75 |
RELX PLC | Industrials | 3.54 |
Increase Decrease New since last portfolio | ||
CT UK Fund Institutional Gross Acc GBP |